About DEMECAN
DEMECAN is a company based in Berlin (Germany) founded in 2017 by Constantin Von Der Groeben, Adrian Fischer, and Cornelius Maurer.. DEMECAN has raised $7.64 million across 1 funding round from investors including b2venture. DEMECAN offers products and services including Medical Cannabis Products, Patientenausweis, and Apotheken-Finder. DEMECAN operates in a competitive market with competitors including Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and Alphargreen Group Limited, among others.
- Headquarter Berlin, Germany
- Founders Constantin Von Der Groeben, Adrian Fischer, Cornelius Maurer
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.64 M (USD)
in 1 rounds
-
Latest Funding Round
$7.64 M (USD), Series A
Oct 01, 2019
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DEMECAN
DEMECAN offers a comprehensive portfolio of products and services, including Medical Cannabis Products, Patientenausweis, and Apotheken-Finder. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-quality cannabis for medical therapy and patient treatment
Secure digital ID for identifying medical cannabis patients
Tool to locate pharmacies offering cannabis-related services
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of DEMECAN
DEMECAN has successfully raised a total of $7.64M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.64 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $7.6M
-
First Round
First Round
(01 Oct 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Series A - DEMECAN | Valuation | b2venture |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DEMECAN
DEMECAN has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include b2venture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to innovative startups by b2venture.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DEMECAN
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DEMECAN
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Demecan Comparisons
Competitors of DEMECAN
DEMECAN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and Alphargreen Group Limited, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabis plants are cultivated in greenhouses for wellness product development.
|
|
| domain | founded_year | HQ Location |
Cannabinoid ingredients for pharmaceuticals are produced via fermentation technology.
|
|
| domain | founded_year | HQ Location |
Cannabis-infused products are developed, manufactured, and distributed for consumers.
|
|
| domain | founded_year | HQ Location |
Cannabis-derived nutritional and wellness products are offered online.
|
|
| domain | founded_year | HQ Location |
Online marketplace for cannabis products treating various diseases is operated.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Demecan
Frequently Asked Questions about DEMECAN
When was DEMECAN founded?
DEMECAN was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is DEMECAN located?
DEMECAN is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Is DEMECAN a funded company?
DEMECAN is a funded company, having raised a total of $7.64M across 1 funding round to date. The company's 1st funding round was a Series A of $7.64M, raised on Oct 01, 2019.
What does DEMECAN do?
DEMECAN, backed by 7641380.0 from b2venture, focuses on healthtech, cannabis healthtech, providing healthcare solutions, and nutraceuticals. Producer of medical cannabis. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of DEMECAN?
DEMECAN's top competitors include Vireo Health, Alphargreen Group Limited and Demetrix.
What products or services does DEMECAN offer?
DEMECAN offers Medical Cannabis Products, Patientenausweis, and Apotheken-Finder.
Who are DEMECAN's investors?
DEMECAN has 1 investor. Key investors include b2venture.